Trial Profile
Safety and Efficacy of Autologous Neural Stem Cell Transplantation in Patients With Traumatic Spinal Cord Injury
Status:
Active, no longer recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Neural cell replacement therapy Ophiuchus Technologies (Primary)
- Indications Spinal cord injuries
- Focus Adverse reactions
- 26 Oct 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 06 Jan 2015 New trial record